This pilot study examined the effects of BPC-157, a synthetic peptide derived from gastric juice, on symptoms in patients with interstitial cystitis (IC). The findings and specific outcomes are not detailed in the information provided, though pilot studies typically involve small patient populations and serve as preliminary investigations before larger trials. This research represents human clinical evidence, though pilot studies have inherent limitations including small sample sizes and lack of control groups.